P1, N=21, Recruiting, City of Hope Medical Center | Trial completion date: Jan 2025 --> Sep 2025 | Trial primary completion date: Jan 2025 --> Sep 2025
over 1 year ago
Trial completion date • Trial primary completion date • Checkpoint inhibition
|
PD-L1 (Programmed death ligand 1)
|
Tecentriq (atezolizumab) • cyclophosphamide • fludarabine IV • CYTO NK-102